AEYE is up +392.76% since Feb ’24 pick Unlock All Top Buy Picks
RSI low/high Values: [ 25 - 75 ]
* StockInvest.us uses dynamically calculated RSI max/min levels to determine when stock is oversold or overbought based on historical behavior.
AI Analysis of BEAT
Powered by GPT-4o
Upgraded!
Stock Analysis
Risk Assessment
Trading Strategy

Big movements in BioTelemetry stock price on Wednesday moving 11.42% between high and low
(Updated on May 22, 2024)

Buy candidate since May 22, 2024 PDF

The BioTelemetry stock price fell by -0.422% on the last day (Wednesday, 22nd May 2024) from $2.37 to $2.36. During the last trading day the stock fluctuated 11.42% from a day low at $2.19 to a day high of $2.44. The price has fallen in 6 of the last 10 days but is still up by 12.92% over the past 2 weeks. Volume fell on the last day along with the stock, which is actually a good sign as volume should follow the stock. On the last day, the trading volume fell by -108 thousand shares and in total, 54 thousand shares were bought and sold for approximately $126.56 thousand.

The stock lies in the middle of a very wide and strong rising trend in the short term and a further rise within the trend is signaled. Given the current short-term trend, the stock is expected to rise 16.72% during the next 3 months and, with a 90% probability hold a price between $2.03 and $2.97 at the end of this 3-month period.

Ready to grow your portfolio? Here's your beginner's guide to opening a free brokerage account.

BEAT Signals & Forecast

The BioTelemetry stock holds buy signals from both short and long-term Moving Averages giving a positive forecast for the stock. Also, there is a general buy signal from the relation between the two signals where the short-term average is above the long-term average. On corrections down, there will be some support from the lines at $2.24 and $2.08. A breakdown below any of these levels will issue sell signals. Furthermore, there is a buy signal from the 3 month Moving Average Convergence Divergence (MACD). Some negative signals were issued as well, and these may have some influence on the near short-term development. A sell signal was issued from a pivot top point on Monday, May 20, 2024, and so far it has fallen -6.72%. Further fall is indicated until a new bottom pivot has been found. Volume fell along with the price during the last trading day, which is technical positive. One should, however, note that this stock may have low liquidity in periods, which increases the general risk.

Support, Risk & Stop-loss for BioTelemetry stock

BioTelemetry finds support from accumulated volume at $2.32 and this level may hold a buying opportunity as an upwards reaction can be expected when the support is being tested.

This stock may move much during the day (volatility) and with periodic low trading volume this stock is considered to be "high risk". During the last day, the stock moved $0.250 between high and low, or 11.42%. For the last week the stock has had daily average volatility of 11.58%.

Our recommended stop-loss: $2.25 (-4.69%) (This stock has high daily movements and this gives high risk. There is a sell signal from a pivot top found 26 days ago.)

Trading Expectations (BEAT) For The Upcoming Trading Day Of Thursday 23rd

For the upcoming trading day on Thursday, 23rd we expect BioTelemetry to open at $2.33, and during the day (based on 14 day Average True Range), to move between $2.18 and $2.54, which gives a possible trading interval of +/-$0.179 (+/-7.57%) up or down from last closing price. If BioTelemetry takes out the full calculated possible swing range there will be an estimated 15.14% move between the lowest and the highest trading price during the day.

Since the stock is closer to the resistance from accumulated volume at $2.37 (0.42%) than the support at $2.32 (1.69%), our systems don't find the trading risk/reward intra-day attractive and any bets should be held until the stock is closer to the support level.

Is BioTelemetry stock A Buy?

Several short-term signals, along with a general good trend, are positive and we conclude that the current level may hold a buying opportunity as there is a fair chance for BioTelemetry stock to perform well in the short-term. We have upgraded our analysis conclusion for this stock since the last evaluation from a Hold/Accumulate to a Buy candidate.

Current score: 1.111 Buy Candidate Upgraded

Predicted Opening Price for BioTelemetry of Thursday, May 23, 2024

Fair opening price May 23, 2024 Current price
$2.33 ( 1.27%) $2.36

The predicted opening price is based on yesterday's movements between high, low, and closing price.

Trading levels for BEAT

Fibonacci Support & Resistance Levels

Level Price
Resistance R3 2.58 9.32 %
R2 2.48 5.28 %
R1 2.43 2.78 %
Current price: 2.36
Support S1 2.23 -5.32 %
S2 2.18 -7.82 %
S3 2.08 -11.86 %

Accumulated Volume Support & Resistance Levels

Level Price
Resistance R3 2.53 7.20 %
R2 2.41 2.12 %
R1 2.37 0.424 %
Current price 2.36
Support S1 2.32 -1.69%
S2 2.05 -13.14%
S3 1.99 -15.68%

FAQ

What is the symbol for BioTelemetry Stock and on which exchange is it traded?
The symbol for BioTelemetry is BEAT and it is traded on the NASDAQ (NASDAQ Stock Exchange).

Should I buy or sell BioTelemetry Stock?
Several short-term signals, along with a general good trend, are positive and we conclude that the current level may hold a buying opportunity as there is a fair chance for BioTelemetry stock to perform well in the short-term. We have upgraded our analysis conclusion for this stock since the last evaluation from a Hold/Accumulate to a Buy candidate.

How to buy BioTelemetry Stock?
BioTelemetry Stock can be purchased through just about any brokerage firm, including online brokerage services.
Click here for our free guide on how to buy BioTelemetry Stock.

What's the current price of BioTelemetry Stock?
As of the end of day on the May 22, 2024, the price of an BioTelemetry (BEAT) share was $2.36.

What is the 52-week high and low for BioTelemetry Stock?
The 52-week high for BioTelemetry Stock is $3.74 and the 52-week low is $1.06.

What is the market capitalization of BioTelemetry Stock?
As of the May 22, 2024, the market capitalization of BioTelemetry is 62.4M.

When is the next earnings date for BioTelemetry?
The upcoming earnings date for BioTelemetry is Aug 08, 2024.
Click to get the best stock tips daily for free!

About BioTelemetry

BioTelemetry HeartBeam, Inc., a medical technology company, primarily focuses on telemedicine solutions for the detection and monitoring of cardiac disease outside a healthcare facility setting. The company also focuses on providing diagnostic data to physicians with care management of patients with cardiovascular disease. Its telehealth product comprises a credit card sized electrocardiogram machine and a cloud-based diagnostic software system to address the... BEAT Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT